|
|
|||||||||
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Samuels is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Tiwari is Mathematical Statistician, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Feuer is Branch Chief, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,372,910 new cancer cases and 570,280 deaths are expected in the United States in 2005. When deaths are aggregated by age, cancer has surpassed heart disease as the leading cause of death for persons younger than 85 since 1999. When adjusted to delayed reporting, cancer incidence rates stabilized in men from 1995 through 2001 but continued to increase by 0.3% per year from 1987 through 2001 in women. The death rate from all cancers combined has decreased by 1.5% per year since 1993 among men and by 0.8% per year since 1992 among women. The mortality rate has also continued to decrease from the three most common cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from breast and colorectal cancers in women. Lung cancer mortality among women has leveled off after increasing for many decades. In analyses by race and ethnicity, African American men and women have 40% and 20% higher death rates from all cancers combined than White men and women, respectively. Cancer incidence and death rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden of suffering and death from cancer can be accelerated by applying existing cancer control knowledge across all segments of the population.
This article has been cited by other articles:
![]() |
J. A. Bonavita, J. Mayo, J. Babb, G. Bennett, T. Oweity, M. Macari, and J. Yee Pattern Recognition of Benign Nodules at Ultrasound of the Thyroid: Which Nodules Can Be Left Alone? Am. J. Roentgenol., July 1, 2009; 193(1): 207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Roccaro, A. Sacco, B. Thompson, X. Leleu, A. K. Azab, F. Azab, J. Runnels, X. Jia, H. T. Ngo, M. R. Melhem, et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma Blood, June 25, 2009; 113(26): 6669 - 6680. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhry and E. Asselin Resistance to chemotherapy and hormone therapy in endometrial cancer Endocr. Relat. Cancer, June 1, 2009; 16(2): 363 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Porterfield, D. A. Factor, and C. S. Grant Operative Technique for Modified Radical Neck Dissection in Papillary Thyroid Carcinoma Arch Surg, June 1, 2009; 144(6): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Davenport, E. M. Caoili, R. H. Cohan, J. H. Ellis, E. J. Higgins, J. Willatt, and G. A. Fox MRI and CT Characteristics of Successfully Ablated Renal Masses: Imaging Surveillance After Radiofrequency Ablation Am. J. Roentgenol., June 1, 2009; 192(6): 1571 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bakir, B. Acunas, D. Bugra, S. Yamaner, O. Asoglu, A. Salmaslioglu, and E. Balik MR Colonography after Oral Administration of Polyethylene Glycol-Electrolyte Solution Radiology, June 1, 2009; 251(3): 901 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Cheung, B. A. Neville, D. B. Cameron, E. F. Cook, and C. C. Earle Comparisons of Patient and Physician Expectations for Cancer Survivorship Care J. Clin. Oncol., May 20, 2009; 27(15): 2489 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tammali, A. B. M. Reddy, K. V. Ramana, J. M. Petrash, and S. K. Srivastava Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation Carcinogenesis, May 1, 2009; 30(5): 799 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Poschmann, B. Sitek, B. Sipos, A. Ulrich, S. Wiese, C. Stephan, B. Warscheid, G. Kloppel, A. Vander Borght, F. C. S. Ramaekers, et al. Identification of Proteomic Differences between Squamous Cell Carcinoma of the Lung and Bronchial Epithelium Mol. Cell. Proteomics, May 1, 2009; 8(5): 1105 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Simon, Y.-H. Chen, and S. Bent The relation of {alpha}-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1558S - 1564S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. TERAO, T. SHIRAKAWA, B. ACHARYA, M. MIYATA, N. HINATA, K. TANAKA, A. TAKENAKA, I. HARA, M. NAOE, K. FUJI, et al. A Pilot Study of Quality of Life of Patients with Hormone-refractory Prostate Cancer after Gene Therapy Anticancer Res, May 1, 2009; 29(5): 1533 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MAMBRINI, P. PACETTI, A. DEL FREO, R. D. SETA, D. PEZZUOLO, T. TORRI, M. ORLANDI, R. TARTARINI, and M. CANTORE Gemcitabine-Capecitabine plus Intra-arterial Epirubicin-Cisplatin in Pretreated Pancreatic Cancer Patients: A Phase I Study Anticancer Res, May 1, 2009; 29(5): 1547 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. SOBTI, L. GUPTA, H. THAKUR, A. SETH, S. K. SINGH, and P. KAUR CYP17 Gene Polymorphism and its Association in North Indian Prostate Cancer Patients Anticancer Res, May 1, 2009; 29(5): 1659 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. SUN, J. HUANG, T. HOMMA, D. KITA, H. KLOCKER, G. SCHAFER, P. BOYLE, and H. OHGAKI Genetic Alterations in the PI3K Pathway in Prostate Cancer Anticancer Res, May 1, 2009; 29(5): 1739 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Krause, K. Herrmann, H. Wieder, and C. M. zum Buschenfelde 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer J. Nucl. Med., May 1, 2009; 50(Suppl_1): 89S - 96S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Azab, J. M. Runnels, C. Pitsillides, A.-S. Moreau, F. Azab, X. Leleu, X. Jia, R. Wright, B. Ospina, A. L. Carlson, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy Blood, April 30, 2009; 113(18): 4341 - 4351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Eckardt, D. L. Bentsion, O. N. Lipatov, I. S. Polyakov, F. R. MacKintosh, D. A. Karlin, G. S. Baker, and H. B. Breitz Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer J. Clin. Oncol., April 20, 2009; 27(12): 2046 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, K. Moissoglu, H. Wang, X. Wang, H. F. Frierson, M. A. Schwartz, and D. Theodorescu Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function PNAS, April 7, 2009; 106(14): 5807 - 5812. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sartori, A. Cavazza, A. Sgambato, A. Marchioni, F. Barbieri, L. Longo, M. Bavieri, B. Murer, E. Meschiari, S. Tamberi, et al. EGFR and K-ras Mutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors Am J Clin Pathol, April 1, 2009; 131(4): 478 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Flanagan, M. Munoz-Alegre, S. Henderson, T. Tang, P. Sun, N. Johnson, O. Fletcher, I. dos Santos Silva, J. Peto, C. Boshoff, et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients Hum. Mol. Genet., April 1, 2009; 18(7): 1332 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Moghaddam, H. Li, S.-N. Cho, M. K. Dishop, I. I. Wistuba, L. Ji, J. M. Kurie, B. F. Dickey, and F. J. DeMayo Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tuncbilek, M. Kaplan, S. Altaner, I. H. Atakan, N. Sut, O. Inci, and M. K. Demir Value of Dynamic Contrast-Enhanced MRI and Correlation with Tumor Angiogenesis in Bladder Cancer Am. J. Roentgenol., April 1, 2009; 192(4): 949 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rozzini and M. Trabucchi Patients With Cancer Who Are Affected by Dementia Do Not Die Only Because of Cancer Arch Intern Med, March 23, 2009; 169(6): 633 - 633. [Full Text] [PDF] |
||||
![]() |
A. M. Puzio-Kuter, M. Castillo-Martin, C. W. Kinkade, X. Wang, T. H. Shen, T. Matos, M. M. Shen, C. Cordon-Cardo, and C. Abate-Shen Inactivation of p53 and Pten promotes invasive bladder cancer Genes & Dev., March 15, 2009; 23(6): 675 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rama, A. Monteiro, J. E. Bernardo, L. Eugenio, and M. J. Antunes Lung metastases from colorectal cancer: surgical resection and prognostic factors Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 444 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maxwell, C. R. McCudden, F. Wians, and M. S. Willis Recent Advances in the Detection of Prostate Cancer Using Epigenetic Markers in Commonly Collected Laboratory Samples Lab Med, March 1, 2009; 40(3): 171 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiozawa, T. Nakanishi, M. Tan, H.-B. Fang, W.-c. Wang, M. J. Edelman, D. Carlton, I. Gojo, E. A. Sausville, and D. D. Ross Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias Clin. Cancer Res., March 1, 2009; 15(5): 1698 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leitner, K. Sweeney, D. Oberg, D. Davies, E. Miranda, N. R. Lemoine, and G. Hallden Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo Clin. Cancer Res., March 1, 2009; 15(5): 1730 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stahl, M. K. Walz, M. Stuschke, N. Lehmann, H.-J. Meyer, J. Riera-Knorrenschild, P. Langer, R. Engenhart-Cabillic, M. Bitzer, A. Konigsrainer, et al. Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction J. Clin. Oncol., February 20, 2009; 27(6): 851 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nasarre, M. Thomas, K. Kruse, I. Helfrich, V. Wolter, C. Deppermann, D. Schadendorf, G. Thurston, U. Fiedler, and H. G. Augustin Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor Growth Cancer Res., February 15, 2009; 69(4): 1324 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kumar, H. Brim, F. Giardiello, D. T. Smoot, M. Nouraie, E. L. Lee, and H. Ashktorab Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans Clin. Cancer Res., February 15, 2009; 15(4): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Sahu and S. K. Srivastava The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate J Natl Cancer Inst, February 4, 2009; 101(3): 176 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruffini, S. Asioli, P. L. Filosso, P. Lyberis, M. C. Bruna, L. Macri, L. Daniele, and A. Oliaro Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann. Thorac. Surg., February 1, 2009; 87(2): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikuchi, V. Margulis, P. I. Karakiewicz, M. Roscigno, S. Mikami, Y. Lotan, M. Remzi, C. Bolenz, C. Langner, A. Weizer, et al. Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma J. Clin. Oncol., February 1, 2009; 27(4): 612 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yildirim, M. Bilici, K. Cayir, V. Yanmaz, S. Yildirim, and S. B. Tekin Serum Adiponectin Levels in Patients with Esophageal Cancer Jpn. J. Clin. Oncol., February 1, 2009; 39(2): 92 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Holt, E. Schulz, and T. A. Wynn Perceptions of the Religion--Health Connection Among African Americans in the Southeastern United States: Sex, Age, and Urban/Rural Differences Health Educ Behav, February 1, 2009; 36(1): 62 - 80. [Abstract] [PDF] |
||||
![]() |
S. Akhtar, S. M. Meeran, N. Katiyar, and S. K. Katiyar Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-Small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors Clin. Cancer Res., February 1, 2009; 15(3): 821 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Smith, B. Nicholson, M. Nitz, H. F. Frierson Jr, M. Smolkin, G. Hampton, W. El-Rifai, and D. Theodorescu Profiling Bladder Cancer Organ Site-Specific Metastasis Identifies LAMC2 as a Novel Biomarker of Hematogenous Dissemination Am. J. Pathol., February 1, 2009; 174(2): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cardarelli and J. E. Thomas Having a Personal Health Care Provider and Receipt of Colorectal Cancer Testing Ann. Fam. Med, January 1, 2009; 7(1): 5 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Madar, R. Brosh, Y. Buganim, O. Ezra, I. Goldstein, H. Solomon, I. Kogan, N. Goldfinger, H. Klocker, and V. Rotter Modulated expression of WFDC1 during carcinogenesis and cellular senescence Carcinogenesis, January 1, 2009; 30(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bulk, B. Sargin, U. Krug, A. Hascher, Y. Jun, M. Knop, C. Kerkhoff, V. Gerke, R. Liersch, R. M. Mesters, et al. S100A2 Induces Metastasis in Non-Small Cell Lung Cancer Clin. Cancer Res., January 1, 2009; 15(1): 22 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mukherjee, G. D. Basu, T. L. Tinder, D. B. Subramani, J. M. Bradley, M. Arefayene, T. Skaar, and G. De Petris Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition J. Immunol., January 1, 2009; 182(1): 216 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melnikov, D. Scholtens, A. Godwin, and V. Levenson Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma J. Mol. Diagn., January 1, 2009; 11(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, S. K. Kang, L. Wang, A. Touijer, and H. Hricak Distribution of Renal Tumor Growth Rates Determined by Using Serial Volumetric CT Measurements Radiology, January 1, 2009; 250(1): 137 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gleisner, M. A. Choti, L. Assumpcao, H. Nathan, R. D. Schulick, and T. M. Pawlik Colorectal Liver Metastases: Recurrence and Survival Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection-Radiofrequency Ablation Arch Surg, December 1, 2008; 143(12): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Hu, D. Meng, and J. Fang Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase Carcinogenesis, December 1, 2008; 29(12): 2369 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, V. Shridhar, and P. Mukherjee Role of Hedgehog Signaling in Ovarian Cancer Clin. Cancer Res., December 1, 2008; 14(23): 7659 - 7666. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Field, S. Kosmider, M. Jefford, R. Jennens, M. Green, and P. Gibbs Chemotherapy Treatments for Metastatic Colorectal Cancer: Is Evidence-Based Medicine in Practice? J. Oncol. Pract, November 1, 2008; 4(6): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Aziz, N. E. Dreckschmidt, and A. K. Verma Plumbagin, a Medicinal Plant-Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer Cancer Res., November 1, 2008; 68(21): 9024 - 9032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Byrne, J. Weissfeld, and M. S. Roberts Anxiety, Fear of Cancer, and Perceived Risk of Cancer following Lung Cancer Screening Med Decis Making, November 1, 2008; 28(6): 917 - 925. [Abstract] [PDF] |
||||
![]() |
A. Bezjak, C. W. Lee, K. Ding, M. Brundage, T. Winton, B. Graham, M. Whitehead, D. H. Johnson, R. B. Livingston, L. Seymour, et al. Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10 J. Clin. Oncol., November 1, 2008; 26(31): 5052 - 5059. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xi, A. Feber, V. Gupta, M. Wu, A. D. Bergemann, R. J. Landreneau, V. R. Litle, A. Pennathur, J. D. Luketich, and T. E. Godfrey Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer Nucleic Acids Res., November 1, 2008; 36(20): 6535 - 6547. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Beck-Fruchter, A. Weiss, and E. Shalev GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data Hum. Reprod. Update, November 1, 2008; 14(6): 553 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hernandez, D. Toledo, D. Martinez, T. Grinan, V. Brito, A. Macias, S. Alfonso, T. Rondon, E. Suarez, A. M. Vazquez, et al. Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody J. Immunol., November 1, 2008; 181(9): 6625 - 6634. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, E. M. Sturgis, A. K. El-Naggar, Q. Wei, and G. Li Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers Carcinogenesis, November 1, 2008; 29(11): 2120 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, N. Kim, B. Dong, D. Boren, S. A. Lee, J. Das Gupta, C. Gaughan, E. A. Klein, C. Lee, R. H. Silverman, et al. Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer J. Virol., October 15, 2008; 82(20): 9964 - 9977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Raji, Y.-F. Kuo, J. L. Freeman, and J. S. Goodwin Effect of a Dementia Diagnosis on Survival of Older Patients After a Diagnosis of Breast, Colon, or Prostate Cancer: Implications for Cancer Care Arch Intern Med, October 13, 2008; 168(18): 2033 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diener, H. Knaebel, S. Witte, I. Rossion, M. Kieser, M. Buchler, C. Seiler, and and the DISPACT Trial Group DISPACT trial: a randomized controlled trial to compare two different surgical techniques of DIStal PAnCreaTectomy -- study rationale and design Clinical Trials, October 1, 2008; 5(5): 534 - 545. [Abstract] [PDF] |
||||
![]() |
Y. Funakoshi, S.-i. Takeda, Y. Kadota, T. Kusu, and H. Maeda Clinical Characteristics and Surgery of Primary Lung Cancer in Younger Patients Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 387 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S-G. Wu, C-H. Gow, C-J. Yu, Y-L. Chang, C-H. Yang, Y-C. Hsu, J-Y. Shih, Y-C. Lee, and P-C. Yang Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Eur. Respir. J., October 1, 2008; 32(4): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh, V. C. Ngo, J. Fargnoli, M. Ayers, K. C. Soo, H. N. Koong, C. H. Thng, H. S. Ong, A. Chung, P. Chow, et al. Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma Clin. Cancer Res., October 1, 2008; 14(19): 6146 - 6153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Grogan, G. J. Stukenborg, A. S. Nagji, W. Simmons, B. D. Kozower, D. R. Jones, and T. M. Daniel Radiotracer-Guided Thoracoscopic Resection is a Cost-Effective Technique for the Evaluation of Subcentimeter Pulmonary Nodules Ann. Thorac. Surg., September 1, 2008; 86(3): 934 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Champion, P. O. Monahan, J. K. Springston, K. Russell, T. W. Zollinger, R. M. Saywell JR, and M. Maraj Measuring Mammography and Breast Cancer Beliefs in African American Women J Health Psychol, September 1, 2008; 13(6): 827 - 837. [Abstract] [PDF] |
||||
![]() |
S. Shah, J. K. Hess-Wilson, S. Webb, H. Daly, S. Godoy-Tundidor, J. Kim, J. Boldison, Y. Daaka, and K. E. Knudsen 2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways Mol. Cancer Res., September 1, 2008; 6(9): 1507 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. An, K. H. Lee, Y. H. Kim, S. H. Park, H. Y. Kim, S. H. Kim, and N. Kim Screening CT Colonography in an Asymptomatic Average-Risk Asian Population: A 2-Year Experience in a Single Institution Am. J. Roentgenol., September 1, 2008; 191(3): W100 - W106. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iwanicki-Caron, F. Di Fiore, I. Roque, E. Astruc, M. Stetiu, A. Duclos, D. Tougeron, S. Saillard, S. Thureau, J. Benichou, et al. Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer J. Clin. Oncol., August 1, 2008; 26(22): 3681 - 3686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parreno, I. Casanova, M. V. Cespedes, J. P. Vaque, M. A. Pavon, J. Leon, and R. Mangues Bobel-24 and Derivatives Induce Caspase-Independent Death in Pancreatic Cancer Regardless of Apoptotic Resistance Cancer Res., August 1, 2008; 68(15): 6313 - 6323. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Assumpcao, M. A. Choti, A. L. Gleisner, R. D. Schulick, M. Swartz, J. Herman, S. L. Gearhart, and T. M. Pawlik Patterns of Recurrence Following Liver Resection for Colorectal Metastases: Effect of Primary Rectal Tumor Site Arch Surg, August 1, 2008; 143(8): 743 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dank, J. Zaluski, C. Barone, V. Valvere, S. Yalcin, C. Peschel, M. Wenczl, E. Goker, L. Cisar, K. Wang, et al. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction Ann. Onc., August 1, 2008; 19(8): 1450 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Kaufman, H.-J. Lenz, J. Marshall, D. Singh, C. Garett, C. Cripps, M. Moore, M. von Mehren, R. Dalfen, W. J. Heim, et al. Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer Clin. Cancer Res., August 1, 2008; 14(15): 4843 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dal Lago, V. D'Hondt, and A. Awada Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors Oncologist, August 1, 2008; 13(8): 845 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Snook, B. J. Stafford, P. Li, G. Tan, L. Huang, R. Birbe, S. Schulz, M. J. Schnell, M. Thakur, J. L. Rothstein, et al. Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity J Natl Cancer Inst, July 2, 2008; 100(13): 950 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, H. Erdem, R. Li, Y. Cai, G. Ayala, M. Ittmann, L.-y. Yu-Lee, S. Y. Tsai, and M.-J. Tsai Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression Cancer Res., July 1, 2008; 68(13): 5460 - 5468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, S. Ranka, and T. Kahveci Classification and feature selection algorithms for multi-class CGH data Bioinformatics, July 1, 2008; 24(13): i86 - i95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Vareed, M. Kakarala, M. T. Ruffin, J. A. Crowell, D. P. Normolle, Z. Djuric, and D. E. Brenner Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1411 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, F.-H. Li, H. Fang, J.-G. Xia, and C.-X. Zhu Correlation of Real-time Gray Scale Contrast-Enhanced Ultrasonography With Microvessel Density and Vascular Endothelial Growth Factor Expression for Assessment of Angiogenesis in Breast Lesions J. Ultrasound Med., June 1, 2008; 27(6): 821 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Moriarty and J. E. Stryker Prevention and screening efficacy messages in newspaper accounts of cancer Health Educ. Res., June 1, 2008; 23(3): 487 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moussa, A. W. Ashton, M. Fraig, E. Garrett-Mayer, M. A. Ghoneim, P. V. Halushka, and D. K. Watson Novel Role of Thromboxane Receptors {beta} Isoform in Bladder Cancer Pathogenesis Cancer Res., June 1, 2008; 68(11): 4097 - 4104. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Lee, H. Tamai, P. Cohen, A. M. Teker, and S. Shu Immunotherapy of Established Murine Squamous Cell Carcinoma Using Fused Dendritic-Tumor Cell Hybrids Arch Otolaryngol Head Neck Surg, June 1, 2008; 134(6): 608 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, A. M. Urvalek, J. Liu, and J. Zhao Activation of KLF8 Transcription by Focal Adhesion Kinase in Human Ovarian Epithelial and Cancer Cells J. Biol. Chem., May 16, 2008; 283(20): 13934 - 13942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Lu, W. Wu, B. Dave, B. M. Slomovitz, T. W. Burke, M. F. Munsell, R. R. Broaddus, and C. L. Walker Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma Clin. Cancer Res., May 1, 2008; 14(9): 2543 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Moore, P. Miketova, M. Hockenberry, K. Krull, A. Pasvogel, M. Carey, and K. Kaemingk Methotrexate-Induced Alterations in Beta-Oxidation Correlate With Cognitive Abilities in Children With Acute Lymphoblastic Leukemia Biol Res Nurs, April 1, 2008; 9(4): 311 - 319. [Abstract] [PDF] |
||||
![]() |
A. Kumar, E. T. Petri, B. Halmos, and T. J. Boggon Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human Cancer J. Clin. Oncol., April 1, 2008; 26(10): 1742 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zerbi, E. Ortolano, G. Balzano, A. Borri, A. A. Beneduce, and V. Di Carlo Pancreatic Metastasis From Renal Cell Carcinoma: Which Patients Benefit From Surgical Resection? Ann. Surg. Oncol., April 1, 2008; 15(4): 1161 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. deBree, H. Rosing, D. Filis, J. Romanos, M. Melisssourgaki, M. Daskalakis, M. Pilatou, E. Sanidas, P. Taflampas, K. Kalbakis, et al. Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study Ann. Surg. Oncol., April 1, 2008; 15(4): 1183 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marur and A. A. Forastiere Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment Mayo Clin. Proc., April 1, 2008; 83(4): 489 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Kohne, G. Folprecht, R. M. Goldberg, E. Mitry, and P. Rougier Chemotherapy in Elderly Patients with Colorectal Cancer Oncologist, April 1, 2008; 13(4): 390 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, J. Liu, J. Li, D. Zhang, M. Liu, J. K. Addo, S. Patil, L. Zhang, J. Yu, J. K. Buolamwini, et al. Anti-cancer Effects of JKA97 Are Associated with Its Induction of Cell Apoptosis via a Bax-dependent and p53-independent Pathway J. Biol. Chem., March 28, 2008; 283(13): 8624 - 8633. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sitnikova, G. Mendese, Q. Liu, B. A. Woda, D. Lu, K. Dresser, S. Mohanty, K. L. Rock, and Z. Jiang IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder Clin. Cancer Res., March 15, 2008; 14(6): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oh, R. S. Herbst, H. Burris, A. Cleverly, L. Musib, M. Lahn, and G. Bepler Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non-Small-Cell Lung Cancer J. Clin. Oncol., March 1, 2008; 26(7): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Bilimoria, A. K. Stewart, D. P. Winchester, and C. Y. Ko The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States Ann. Surg. Oncol., March 1, 2008; 15(3): 683 - 690. [Full Text] [PDF] |
||||
![]() |
G. T. Stathopoulos, T. P. Sherrill, W. Han, R. T. Sadikot, F. E. Yull, T. S. Blackwell, and B. Fingleton Host Nuclear Factor-{kappa}B Activation Potentiates Lung Cancer Metastasis Mol. Cancer Res., March 1, 2008; 6(3): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |